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Abstract
Gap junction proteins form the substrate for electrical coupling between neurons. These electrical
synapses are widespread in the central nervous system and serve a variety of important functions. In
the retina, connexin 36 (Cx36) gap junctions couple AII amacrine cells and are a requisite component
of the high-sensitivity rod photoreceptor pathway. AII amacrine cell coupling strength is dynamically
regulated by background light intensity, and uncoupling is thought to be mediated by dopamine
signaling via D1-like receptors. One proposed mechanism for this uncoupling involves dopamine-
stimulated phosphorylation of Cx36 at regulatory sites, mediated by protein kinase A. Here we
provide evidence against this hypothesis and demonstrate a direct relationship between Cx36
phosphorylation and AII amacrine cell coupling strength. Dopamine receptor-driven uncoupling of
the AII network results from protein kinase A activation of protein phosphatase 2A and subsequent
dephosphorylation of Cx36. Protein phosphatase 1 activity negatively regulates this pathway. We
also find that Cx36 gap junctions can exist in widely different phosphorylation states within a single
neuron, implying that coupling is controlled at the level of individual gap junctions by locally
assembled signaling complexes. This kind of synapse-by-synapse plasticity allows for precise control
of neuronal coupling, as well as cell type-specific responses dependent on the identity of the signaling
complexes assembled.
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Introduction
Electrical synapses formed by gap junctions between neurons underlie a number of important
neural functions, including neuronal synchronization (Deans et al., 2001), signal averaging
(DeVries et al., 2002), and network oscillations (Hormuzdi et al., 2001; Buhl et al., 2003), in
addition to providing an alternative form of synaptic connection with properties that differ
distinctly from the more common chemical synapses. Connexin 36 (Cx36) is the most widely
expressed gap junction protein in neurons (Connors, 2009), but little is known about how
intercellular coupling mediated by Cx36 is regulated. Loss of Cx36 eliminates electrical
coupling and coordinated output in certain cortical interneurons (Deans et al., 2001), impairs
gamma frequency oscillations in hippocampus (Hormuzdi et al., 2001; Buhl et al., 2003),
causes deficits in cerebellar motor learning (Van Der Giessen et al., 2008), and eliminates the
high-gain rod photoreceptor pathway (Guldenagel et al., 2001; Deans et al., 2002; Volgyi et
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al., 2004). Cx36 is also the dominant connexin in pancreatic beta cells (Serre-Beinier et al.,
2008), and loss of these gap junctions causes insulin secretion abnormalities that resemble
those observed in type 2 diabetes (Wellershaus et al., 2008). Thus, understanding the regulation
of Cx36 channel function is of critical importance to understanding brain and sensory system
function as well as endocrine function.
The retina is an ideal tissue for studying regulation of gap junction-mediated coupling; every
class of retinal neuron expresses gap junction proteins (Bloomfield and Volgyi, 2009), and the
tissue remains physiologically intact when isolated from the eye. In mammalian retina the AII
amacrine cell, which receives input from rod bipolar cells (Strettoi et al., 1990) and is critical
for rod-mediated vision (Guldenagel et al., 2001; Deans et al., 2002; Volgyi et al., 2004), is a
well-established model for studying Cx36-mediated coupling (Famiglietti and Kolb, 1975;
Mills and Massey, 1995; Feigenspan et al., 2001; Mills et al., 2001; Veruki and Hartveit,
2002; Xia and Mills, 2004; Veruki et al., 2008). AII amacrine cells are extensively coupled to
each other by Cx36 gap junctions under scotopic background light and are uncoupled in
response to photopic background light (Bloomfield et al., 1997; Bloomfield and Volgyi,
2004), dopamine D1-like receptor (D1R) activation (Hampson et al., 1992), and protein kinase
A (PKA) activation (Mills and Massey, 1995; Urschel et al., 2006). Studies in cell cultures
have identified two phosphorylation sites on the fish homologue of Cx36, Ser110 and Ser276
(Ser293 in mammals), that are required for regulation of Cx36-mediated coupling by PKA
(Ouyang et al., 2005). These sites have been shown to undergo dynamic changes in
phosphorylation state in the retina (Kothmann et al., 2007). We therefore sought to determine
the relationship between Cx36 phosphorylation and regulation of Cx36-mediated coupling by
utilizing the well-described AII amacrine cell system.
Materials and Methods
Intracellular injection
Care and use of experimental animals was performed in accordance with institutional
guidelines at the University of Texas Health Science Center at Houston. All experiments were
performed on light-adapted animals in the daytime phase of their light cycle. Adult rabbits
were anesthetized with urethane (1.5 g/kg, i.p.), and the eyes removed into Ames medium
bubbled with 95% O2/5% CO2. Following this, the animals were killed by intracardial injection
with an overdose of urethane. The superior portion of the retina was separated into several
retina-sclera pieces, which were then incubated with DAPI (4,6-diamino-2-phenylindole;
Molecular Probes; Eugene, OR) for 20 minutes to label cell nuclei (this short incubation labels
AII amacrine cells preferentially (Mills and Massey, 1991)). Immediately before each piece
was to be injected, the retina was isolated and mounted photoreceptor-side down on black
nitrocellulose filters. Neurobiotin (3.5%; Vector Laboratories; Burlingame, CA) was injected
by iontophoresis (±1 nA, 3 Hz) into AII amacrine cells, as described previously in detail (Xia
and Mills, 2004), except that Alexa 488-conjugated biocytin (Molecular Probes) was used to
visualize the microelectrode. Injections were performed for 5 minutes on an Olympus BX51WI
microscope; this was followed by a 15 minute diffusion period. Each piece was superfused,
starting 15 minutes prior to the start of the injection and on through the diffusion period, with
either bubbled Ames medium (at 35°C) or Ames medium containing D1R agonist (SKF38393,
10 or 100 µM) or antagonist (SCH23390, 10 or 100 µM). After tracer injection and diffusion
periods, the pieces of retina were fixed for 15 minutes in 4% formaldehyde in 0.1 M phosphate
buffer, and subsequently immunolabeled for Cx36 and phospho-Ser293-Cx36 (Kothmann et
al., 2007). Dopaminergic drugs were purchased from Tocris (Ellisville, MO).
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Pharmacology experiments
Rabbit eyecups with the vitreous removed were separated into superior and inferior portions
by chopping along the myelinated band with a razor blade. The central portion of the superior
part from a single eye was then further separated into 4 adjacent retina-sclera pieces. Each
retina-sclera piece was incubated for 20 minutes in bubbled Ames medium (at 35°C) with the
appropriate pharmacologic agent. Thus, each experiment yielded one control piece and three
matched pieces subjected to various pharmacological treatments. Following the incubation
period, the retina-sclera pieces were fixed for 15 minutes in 4% formaldehyde in 0.1 M
phosphate buffer, after which the retina was isolated, mounted photoreceptor-side down on
nitrocellulose filters, and immunolabeled for Cx36 and phospho-Ser293-Cx36. The cAMP
analogs were purchased from Axxora (San Diego, CA) the microcystin-LR from Calbiochem
(San Diego, CA), and the tautomycetin from Tocris.
Immunolabeling
Isolated retina pieces (photoreceptor-side down on nitrocellulose filters) were first blocked
overnight at 10°C in immunolabeling buffer (phosphate buffered saline with 0.5% Triton
X-100, 0.1% NaN3, pH 7.4) with 10% normal donkey serum (Jackson Immunoresearch; West
Valley, PA). Pieces were then labeled with monoclonal mouse anti-Cx36 (mCx36, 1:1,000
dilution; Chemicon; Temecula, CA) and rabbit anti-phospho-Ser293-Cx36 (Ser293-P, 1:1,000
dilution) (Kothmann et al., 2007) antibodies in immunolabeling buffer with 10% donkey serum
for 5 days at 10°C. Retina pieces from pharmacology experiments were also labeled with goat
anti-calretinin antibodies (1:5,000 dilution; Chemicon) to label AII amacrine cells. After
extensive washing, retina pieces were labeled with secondary antibodies (1:500 dilutions) in
immunolabeling buffer with 5% donkey serum overnight at 10°C. For retina pieces from
injection experiments, anti-calretinin labeling was replaced with Alexa 488-conjugated
streptavidin (1:250 dilution) to label Neurobiotin in the injected network. Alexa 488-
conjugated streptavidin and secondary antibodies were purchased from Molecular Probes. All
other secondary antibodies were Cy3- or Cy5-conjugated (Jackson). Retina pieces were whole-
mounted on slides with Vectashield (Vector).
Imaging and data quantification
Images were collected on a Zeiss LSM 510 Meta confocal microscope using a 63x (1.4 N.A.)
or 40x (1.3 N.A.) oil immersion objectives. Imaging settings in the LSM software were
identical where comparisons are made. Coupling between AII amacrine cells was quantified
as the diffusion coefficient for Neurobiotin tracer transfer using a 2-dimensional
compartmental diffusion model (Xia and Mills, 2004). Cx36 phosphorylation was quantified
as the ratio of the mean intensity of Ser293-P to mCx36 immunofluorescence at individual
regions of interest (ROIs), each identified by the mCx36 label as a single Cx36 gap junction
plaque. ROI identification was accomplished using SimplePCI software (Compix; Sewickley,
PA) to analyze single optical sections. ROI borders were defined by a 20% intensity threshold
in the mCx36 channel and a size threshold of 0.15 µm2. For the pharmacology experiments,
an additional, empirically determined intensity threshold was added in the calretinin channel
to include only the Cx36 gap junctions localized on the AII network. In our hands, this
represents 96% of the Cx36 gap junctions in stratum 5 of the rabbit inner plexiform layer, in
good agreement with a previously reported value of 98% (Mills et al., 2001). In the case of
injected AII networks, single optical sections were collected focused on the distal dendrites of
the injected cell, and all gap junctions in the field of view were included. Since 96–98% of the
gap junctions at this focus depth in the retina are on AIIs, even when Neurobiotin diffusion
was weak there was a very low probability of including Cx36 plaques that were not on AII
amacrine cells.
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In the pharmacology experiments, six images were collected at mid-peripheral eccentricity
from each condition; in the injection experiments, three images were collected on different
sides of each injected cell. The ratio of the mean intensity of Ser293-P to mCx36
immunofluorescence was calculated for each ROI and averaged across all ROIs in all images
per condition. In this way, we collapsed the phosphorylation data into one value per condition
per animal in order to perform statistical analysis.
In order to calculate the fraction of Cx36 plaques that showed any detectable phospho-Ser293
antibody labeling, regardless of its intensity, we first measured the background labeling in the
Ser293-P channel for all images (measured in areas where no mCx36 labeling existed). We
then set a threshold for detectable labeling at 200% of the mean background value (this value
approximated the mean + 2 s.d. of the background levels observed in the initial experiments).
Any Cx36 gap junction plaque with Ser293-P labeling above this threshold was considered
“detectably phosphorylated” for purposes of calculating the fraction of plaques showing
phosphorylation.
Images presented in the figures were collected using identical settings in the LSM software.
Processing was limited to application of a 10% intensity threshold in all channels to minimize
background noise.
Statistical analysis
A linear regression was used to find the correlation between relative Cx36 phosphorylation
and AII amacrine cell coupling. Unpaired, two-tailed t-tests were used to compare each drug-
treated condition with the control condition from the same animal. Unpaired, two-tailed t-tests
were also used to compare two drug-treated conditions that shared one common drug (such as
D1R agonist condition vs. D1R agonist plus phosphatase inhibitor).
Results
AII amacrine cell uncoupling is associated with dephosphorylation of Cx36
We combined intracellular injection of the Cx36-permeant tracer Neurobiotin with
immunolabeling for phospho-Ser293-Cx36 in order to measure AII amacrine cell coupling and
Cx36 phosphorylation in isolated rabbit retina. As previously reported (Hampson et al.,
1992), AII-AII coupling was modulated by dopamine signaling (Fig.1, A–C). Activation of
D1Rs (SKF38393, 10 µM) reduced AII-AII coupling (Fig. 1B), while antagonism of D1Rs
(SCH23390, 100 µM) increased coupling (Fig. 1C). Phosphorylation of Cx36 at Ser293
(Ser293-P) was assessed at gap junctions on the injected AII amacrine cell dendrites and those
nearby (Fig. 1, D–F; see Methods). Ser293-P was decreased by D1R activation (Fig. 1H)
relative to control (Fig. 1G). Consistent with this, D1R antagonism increased Ser293-P (Fig.
1I). In order to quantify AII amacrine cell coupling, we used a compartmental diffusion model
to estimate the diffusion coefficient of the Neurobiotin tracer (Xia and Mills, 2004). We
quantified Ser293-P as a ratio of the mean fluorescence intensity of the phospho-Ser293-Cx36
antibody to the mean fluorescence intensity of a monoclonal Cx36 antibody at each individual
gap junction plaque (for full details see Methods section). We collected three images focused
on the dendrites of each injected AII amacrine cell, calculated the mean Ser293-P for all Cx36
plaques detected across all three images, and plotted this against the diffusion coefficient for
Neurobiotin tracer transfer measured for that AII amacrine network (Fig. 1J). A strong
correlation (r2 = 0.86) was found between AII amacrine cell coupling and Cx36
phosphorylation at Ser293. Since Ser293 is known to regulate coupling through Cx36 gap
junctions (Ouyang et al., 2005), this finding leads us to conclude that phosphorylation at this
site increases coupling.
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D1R-stimulated dephosphorylation of Cx36 is mediated by PKA
The canonical D1R signaling pathway involves a Gs-protein that activates adenylyl cyclase,
thereby elevating [cAMP]i to activate PKA (Neve et al., 2004). We therefore examined the
role of PKA activity in controlling Cx36 phosphorylation state downstream of D1R signaling
using retina-sclera preparations (Fig. 2; see Methods). D1R activation (SKF38393, 100 µM)
caused a 3.5-fold reduction in Ser293-P intensity (Fig. 2D). Inhibition of PKA (Rp-8-CPT-
cAMPS, 20 µM) significantly suppressed the effect of D1R activation (Fig. 2F), resulting in
intermediate Cx36 phosphorylation that was below control levels but above the levels seen
with D1R activation alone. D1R antagonism (SCH23390, 100 µM) caused a 2-fold increase
in Cx36 phosphorylation (Fig. 2H). As a second measure of the effects of these treatments, we
determined if they altered the fraction of Cx36 plaques that showed detectable Ser293-P
labeling, regardless of fluorescence intensity. Detectable Ser293-P labeling was defined as
200% of the background fluorescence in that channel (see Methods); this equated
approximately to a 5% threshold in the Ser293-P channel. This measure yielded results
consistent with the mean Ser293-P measurements (Fig. 2J). Histograms of the ratio of Ser293-
P to mCx36 fluorescence from one representative experiment showed that D1R activation
caused a leftward-shift (reduction in Ser293-P) in the population of Cx36 plaques which was
blocked by inhibition of PKA, while D1R antagonism caused a rightward-shift (increase in
Ser293-P) in the Cx36 population (Fig. S1). These results lead us to conclude that activation
of PKA is a component of the pathway regulating Cx36-mediated coupling of AII amacrine
cells. However, these results are not consistent with direct phosphorylation of Ser293 by PKA,
since inhibition of this kinase led to a net increase in Cx36 phosphorylation.
We also tested the effects of dopamine itself on Cx36 phosphorylation at Ser293 in AII
amacrine cells. Consistent with the effects of D1R agonist, dopamine application (1 µM) caused
a 4-fold reduction in Ser293-P intensity (control, mean ratio 0.41 ± 0.06 s.e.m.; dopamine,
mean ratio 0.096 ± 0.02 s.e.m.; n = 4, p < 0.01), as well as a similar reduction in the percentage
of Cx36 plaques that showed detectable Ser293-P labeling (control, mean 69 ± 6%; dopamine,
mean 19 ± 8%; n = 4, p < 0.01) (Fig. S2). This concentration of dopamine represents the upper
end of estimates of the physiological extracellular dopamine concentration in the vertebrate
retina (Witkovsky et al., 1993), and is known to strongly uncouple AII amacrine cells
(Hampson et al., 1992;Mills and Massey, 1995). Thus, endogenous levels of dopamine should
be sufficient to drive dephosphorylation of Cx36.
Modulation of Cx36 phosphorylation at Ser293 could alter coupling between AII amacrine
cells in several ways. It could modulate the permeability of Cx36 gap junctions to the
Neurobiotin tracer, stimulate insertion or removal of gap junction proteins from the plasma
membrane at each Cx36 plaque, or cause changes in the number of gap junction plaques
between AII amacrine cells. Changes in Ser293-P caused by D1R receptor activation
(SKF38393, 100 µM) or antagonism (SCH23390, 100 µM) had no effect on the mean plaque
size of Cx36 gap junctions or the mean number of plaques on AII dendrites in a given area
(Fig. 3). Thus, the changes in tracer coupling between AII amacrine cells presented above
cannot be attributed to changes in the trafficking of Cx36 proteins or the number of Cx36 gap
junctions connecting AII amacrine cells. Rather, it appears that phosphorylation of Ser293
must modulate the permeability of Cx36 to the Neurobiotin tracer.
PP2A is required for D1R-stimulated dephosphorylation of Cx36
Because D1R activation reduced Ser293-P, we hypothesized that dopamine signaling increases
overall phosphatase activity at Cx36 gap junctions in AII amacrine cells. In eukaryotic cells
protein phosphatase 1 (PP1) and protein phosphatase 2A (PP2A) are the most abundant
phosphatases (Virshup and Shenolikar, 2009); thus, we initially targeted these proteins as
potential effectors of D1R-stimulated dephosphorylation of Cx36. We tested the ability of D1R
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agonist to reduce Ser293-P in the presence of different phosphatase inhibitors at concentrations
that preferentially inhibit either PP1 or PP2A. Microcystin-LR (0.5 nM), an inhibitor with
higher affinity for PP2A (IC50 = 40 pM) than for PP1 (IC50 = 1.7 nM) (Honkanen et al.,
1990), completely blocked the reduction of Ser293-P caused by D1R activation (SKF38393,
10 µM) (Fig. 4F). Application of microcystin-LR alone significantly increased Ser293-P levels
relative to control (Fig. 4H), similar to the effect of D1R antagonist application. Contrasting
these results, tautomycetin (10 nM), an inhibitor with higher affinity for PP1 (IC50 = 1.6 nM)
than for PP2A (IC50 = 62 nM) (Mitsuhashi et al., 2001), did not prevent the D1R-mediated
reduction of Ser293-P (Fig. 5F). Interestingly, inhibition of PP1 with tautomycetin in the
absence of D1R activation was sufficient to cause a robust reduction in Ser293-P (Fig. 5H).
As shown in the previous experiments, the percentage of Cx36 plaques showing detectable
Ser293-P labeling followed the same pattern revealed by measuring the mean Ser293-P for
both PP2A and PP1 inhibitors (Fig. 4J and Fig. 5J). These results provide a measure of
confidence that the concentrations of microcystin-LR and tautomycetin used were selective
for PP2A and PP1, respectively, as only microcystin-LR was able to block the effects of D1R
activation, and since they had opposite effects on Cx36 phosphorylation when applied alone.
Together, these experiments argue that PP2A is a necessary component of the D1R pathway
regulating Cx36 phosphorylation and coupling strength between AII amacrine cells, and these
results are consistent with direct dephosphorylation of Ser293 by PP2A. These experiments
also provide evidence that PP1 is involved in regulating Cx36-mediated coupling of AII
amacrine cells. However, these results are not consistent with PP1 acting directly on Ser293.
Rather, they indicate that PP1 negatively regulates the pathway leading to dephosphorylation
of Ser293, although the exact mechanism for this action is unclear.
PKA drives PP2A-mediated dephosphorylation of Cx36
Based on the results showing that both PKA and PP2A are downstream of D1R activation, we
next asked if PP2A itself is activated by PKA in AII amacrine cells. Such a pathway has recently
been described in medium-sized, spiny neurons in the striatum, where D1R-stimulated
activation of PKA causes phosphorylation of the regulatory subunit of PP2A and thus increases
the activity of the phosphatase (Ahn et al., 2007). These striatal neurons bear certain similarities
to AII amacrine cells (namely, D1R and DARPP-32 expression) (Partida et al., 2004;
Svenningsson et al., 2004; Witkovsky et al., 2007). In order to test this hypothesis, we bypassed
D1Rs and directly stimulated PKA. PKA activation (Sp-8-CPT-cAMPS, 20 µM) strongly
reduced mean Ser293-P in AII amacrine cells (Fig. 6D), just as D1R activation did. Inhibition
of PP2A (microcystin-LR, 0.5 nM) completely blocked the PKA-mediated reduction in
Ser293-P (Fig. 6F). Inhibition of PP2A alone caused a trend toward increased phosphorylation
of Ser293-P (Fig. 6I), similar to the to the significant increase noted above (Fig. 4). As before,
the percentage of Cx36 plaques showing detectable phospho-antibody labeling followed the
same pattern established by measuring the mean Ser293-P intensity (Fig. 6J). These results
confirm that PP2A is required for PKA-dependent dephosphorylation of Cx36 in AII amacrine
cells, and support the existence of the D1R → PKA → PP2A pathway in these neurons.
Phosphorylation of Cx36 is controlled independently at each gap junction plaque
We frequently observed that Cx36 gap junctions in close proximity of each other existed in
very different phosphorylation states, even across gap junctions positioned along a single
dendrite. This was most apparent in control conditions (Fig. 2A & B, arrowheads; also Fig. S1
D). Pharmacologic activation of D1Rs reduced the heterogeneity observed in Ser293-P by
causing a strong reduction in the relative degree of phosphorylation at each Cx36 plaque.
Conversely, antagonism of D1Rs led to an increase in the relative degree of phosphorylation
at each Cx36 plaque, indicating that dopamine-driven dephosphorylation of Cx36 is opposed
by an unknown process. Thus, it appears that our control condition represents a near-
equilibrium point, where conditions at some gap junction plaques favor phosphorylation of
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Cx36 and conditions at others favor dephosphorylation of Cx36. The observation that this
variation exists even for pairs of Cx36 plaques within a micron of one another suggests that
each Cx36 gap junction plaque functions as an individual unit, the regulation of which is at
least partially controlled by very local processes.
Overall, we have quantitatively demonstrated the relationship between AII amacrine cell
uncoupling and Cx36 dephosphorylation. Our results describe a D1R → PKA → PP2A
pathway that mediates the dephosphorylation of Cx36 at Ser293, and thus the D1R-mediated
uncoupling of AII amacrine cells (Fig. 7). PP1 activity negatively regulates this
dephosphorylation pathway at an unknown point. Our results indicate regulation is likely
controlled at the level of individual Cx36 plaques, and that phosphorylation of Ser293 appears
to influence permeability of these gap junctions, but not the trafficking of Cx36.
Discussion
One fundamental function of the retina is to adapt to fluctuating background illumination.
Electrical coupling between AII amacrine cells increases the signal to noise ratio of their
response to light (Vardi and Smith, 1996; Dunn et al., 2006). Modulation of coupling strength
between AII amacrine cells serves to optimize signal to noise ratio for prevailing background
illumination, and is one mechanism the retina uses to accomplish luminance adaptation
(Bloomfield and Volgyi, 2004). In darkness AIIs are relatively uncoupled, thus preserving
single-photon responses in a small group of AIIs. Coupling increases greatly under low scotopic
to mesopic illumination, allowing for summation of coincident signals and improved signal to
noise ratio. The AII network is uncoupled under photopic illumination by dopamine signaling.
This may act to prevent contamination of cone photoreceptor signals in cone bipolar cells by
saturated rod signals in AII amacrine cells. In addition, AIIs provide inhibitory glycinergic
input to Off cone bipolar cells (Strettoi et al., 1992) and some Off ganglion cells (Manookin
et al., 2008; Murphy and Rieke, 2008; Munch et al., 2009). Thus uncoupling of the AII network
should also act to increase the spatial resolution of On cone bipolar cell-driven feed-forward
inhibition of Off cone bipolar and retinal ganglion cells.
Previously it was unclear what molecular mechanism modulates coupling through Cx36 gap
junctions. Although increased phosphorylation of Cx36 has been implicated as a mechanism
for uncoupling gap junctions based on the dependence on PKA activity (Ouyang et al., 2005;
Urschel et al., 2006), this has not been directly assessed. By making quantitative measures of
tracer diffusion between AII amacrine cells and the relative phosphorylation of Cx36 gap
junctions between these cells, we have determined that dephosphorylation of Ser293 is
associated with uncoupling of the AII amacrine cell network. Decreases in both coupling and
phosphorylation are triggered by dopamine D1R signaling and are mediated (at least in part)
by activation of PKA. This finding, together with the previous finding that the Ser293
phosphorylation site is one of two that are required for regulation of Cx36 coupling by PKA
activity (Ouyang et al., 2005), provides strong evidence that dephosphorylation of Cx36 at
Ser293 is the mechanism by which Cx36 gap junctions are uncoupled.
It has been reported that SCH23390 (10 µM) blocks the uncoupling effect of exogenous
dopamine (100 nM) application (Hampson et al., 1992). It is thus curious that in our hands 10
µM SCH23390 did not alter AII amacrine cell coupling, but 100 µM SCH23390 increased
coupling. However, technical differences between our tracer coupling measurements and those
made in the previous study preclude direct comparison. Hampson et al. (1992) used a more
sensitive but nonlinear (peroxidise amplification) tracer detection method and 3 to 4-fold longer
diffusion periods, potentially amplifying small effects. It is difficult to precisely identify the
reason that a high concentration of SCH23390 was required to increase coupling in our
experiments. It is possible that the non-specific binding of the drug to other targets with low-
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affinity binding sites (Leonard et al., 2006; Ekelund et al., 2007) caused network effects that
led to increased AII amacrine cell coupling. However, given that both the D1R agonist
SKF38393 (10 µM) and dopamine (1 µM) effectively drove reductions in AII amacrine cell
coupling, the specific action of SCH23390 on D1-like dopamine receptors seems most likely.
The molecular mechanism by which phosphorylation of Ser293 alters coupling through Cx36
gap junctions is still a topic for further study. We have excluded changes in the trafficking of
Cx36 proteins and reduction in the absolute number of Cx36 gap junctions on AII amacrine
cells as potential mechanisms by which dephosphorylation of Cx36 reduces coupling. Thus,
it seems likely that dephosphorylation of Cx36 reduces its permeability to the Neurobiotin
tracer. The question of what dephosphorylation of Cx36 does to the single-channel conductance
and/or open probability or open duration of the channel is of more biological significance in
neurons. Although our experiments here cannot directly address this measure of channel
function, it has recently been shown that the junctional conductance between pairs of AII
amacrine cells can change dynamically up to six-fold (Veruki et al., 2008). This increase was
time-dependent and was observed with low-resistance patch pipettes, but not with high-
resistance pipettes, leading the authors to suggest that the increase in coupling was due to
gradual washout of an endogenous regulatory system in the AII amacrine cell. Washout of
cAMP is the most prominent initial candidate, and should result in a gradual increase in the
phosphorylation of Cx36.
Our results indicate that the D1R- and PKA-dependent dephosphorylation of Cx36 in AII
amacrine cells requires PP2A activation. A D1R → PKA → PP2A pathway also exists in
medium-sized spiny neurons of the striatum, in which Thr75 of dopamine- and cyclic-AMP-
regulated phosphoprotein (DARPP-32) is one substrate for PP2A (Ahn et al., 2007). This
dephosphorylation allows PKA to phosphorylate Thr34 of DARPP-32, thereby converting it
into a potent inhibitor of PP1 (Svenningsson et al., 2004). DARPP-32 is also expressed by AII
amacrine cells (Partida et al., 2004; Witkovsky et al., 2007), and we show that while PP1
inhibition does not mediate D1R-stimulated dephosphorylation of Cx36, PP1 inhibition alone
is sufficient to cause Ser293 dephosphorylation. As PKA activation of PP2A in the striatal
spiny neuron was caused by phosphorylation of the regulatory subunit of PP2A (Ahn et al.,
2007), one explanation for our finding is that PP1 activity may oppose PKA-dependent
activation of PP2A by phosphorylation (Fig. 7), although we did not explicitly test this
hypothesis. It is clear from our results that the dopamine D1R → PKA → PP2A pathway is
not limited to the striatal neurons where it was first described, but is also a component of
dopamine signaling in other neurons, such as the AII amacrine cell.
In the retina, dopamine signaling originates from dopaminergic amacrine cells and is associated
with light adaptation (Witkovsky, 2004). In addition to the AII amacrine cell, dopamine
modulates the coupling state of other Cx36-coupled retinal neurons, such as cone
photoreceptors (Lee et al., 2003; O'Brien et al., 2004; Zhang and Wu, 2004; Ribelayga et al.,
2008) and OFF α ganglion cells (Hidaka et al., 2002; Mills et al., 2007). In both of these cases,
however, activation of D2-like dopamine receptors triggers the uncoupling. This suggests that
in cones and OFF α ganglion cells, reduced [cAMP]i and reduced PKA activity mediate
uncoupling. Based on the relationship between Cx36 phosphorylation and AII amacrine
coupling strength that we describe here, we would predict that in cones and OFF α ganglion
cells PKA acts directly on Cx36 proteins, rather than activating a phosphatase effector, and in
cones this appears to be the case (H. Li, A. Chuang, & J.O., 2009; manuscript submitted for
publication). Previous reports support this possibility, as we and others have shown that PKA
can directly phosphorylate regulatory residues on Cx36 in vitro (Ouyang et al., 2005; Urschel
et al., 2006; Kothmann et al., 2007). Thus, regulation of Cx36-mediated coupling is specific
to individual neuronal subtypes in the retina and is dependent on the signaling pathways they
express.
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The specificity of regulation that we observe in retinal neurons indicates that the signaling
pathways that control coupling are likely to vary in other Cx36-coupled networks, such as those
found in cortex, hippocampus, cerebellum and inferior olive, and elsewhere. For instance,
several kinases converge onto the regulatory phosphorylation sites of Cx36 in vitro, including
PKA, PKG, and CamKII (Ouyang et al., 2005; Patel et al., 2006; Urschel et al., 2006; Kothmann
et al., 2007; Alev et al., 2008), suggesting that many common signaling pathways can modulate
coupling. The importance of regulation of Cx36-mediated coupling in other networks is
currently not well understood, as most studies have focused on the consequences of complete
loss of Cx36-mediated coupling (Deans et al., 2001; Buhl et al., 2003; Van Der Giessen et al.,
2008). The results we present here provide a framework for future study of coupling in these
systems, where increased phosphorylation of Ser293 indicates increased coupling, and vice
versa.
We commonly observed heterogeneity of Cx36 phosphorylation within individual AII
amacrine cells under control conditions. This observation implies that Cx36 phosphorylation,
and thus coupling, is controlled at the level of individual gap junction plaques. This possibility
evokes comparisons to the postsynaptic density found at chemical synapses, where complexes
of signaling proteins are assembled and provide synapse-specific modulation of important
synaptic elements, such as glutamate receptors (Soderling and Derkach, 2000; Feng and Zhang,
2009). The C-terminal tail of Cx36 binds PDZ domain-containing proteins (Li et al., 2004),
and may bind some of the same molecules that form the scaffolding complex at the postsynaptic
density. Additionally, CamKII can bind directly to Cx36 (Alev et al., 2008), providing the
means for localization of one potential regulator of coupling.
Local control of coupling would allow for the possibility of activity-dependent regulation of
individual electrical synapses. This is particularly interesting to consider in the case of the AII
amacrine cell, which shifts from uncoupled in dark-adapted retina to well-coupled through
most of the scotopic range of vision, and which finally becomes uncoupled again under
photopic visual conditions (Bloomfield and Volgyi, 2004) as a result of dopamine signaling.
What causes the increase in coupling when background illumination increases from darkness
to scotopic levels? One possibility is that glutamate release from rod bipolar cells causes
Ca++ influx in the AII dendrites, leading to activation of CamKII and phosphorylation of Cx36,
thus increasing coupling in a manner dependent on presynaptic activity. There are several
potential sources of Ca++ on AII dendrites, including Ca++-permeable AMPA receptors and
NMDA receptors (Hartveit and Veruki, 1997; Morkve et al., 2002). One possible role for
locally increasing coupling in an activity-dependent manner is to allow the spread and
summation of signals from active rod bipolar cells in AII amacrine cells when photon catch is
very low (near visual threshold). Gap junctions not in the vicinity of an active rod bipolar cell
would remain uncoupled, and thus reduce the sharing of noisy fluctuations in the AII membrane
potential. This could be particularly important in AIIs, which are inherently noisy due to the
nature of the rod bipolar to AII amacrine synaptic inputs (Dunn et al., 2006). As background
light intensity increases in the scotopic range, additional rod bipolar cells will become active,
and continue to increase AII amacrine cell coupling, as has been described (Bloomfield and
Volgyi, 2004).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. AII amacrine cell coupling is directly related to Cx36 phosphorylation at Ser293
A–C, Neurobiotin tracer coupling between AII amacrine cells is modulated by dopamine D1R
signaling. D1R activation (B, SKF38393, 10 µM) reduced the extent of Neurobiotin diffusion
relative to control (A). D1R antagonism (C, SCH23390, 100 µM) increased tracer diffusion.
Images are mini-stacks (2 µm in z-depth) focused on the somas of the AII amacrine cells.
Yellow boxes highlight areas shown in D–I (at different focal depth). D–F, Cx36 gap junctions,
labeled with mCx36 antibody (red) and Ser293-P antibody (green), on and around the dendrites
of the injected AII amacrine cell, labeled with fluorophore-conjugated Streptavidin (blue). The
Cx36 gap junctions not on the injected cell are primarily on other AII amacrine cells (see
Methods). Arrowheads identify prominent Cx36 gap junctions on the injected cells. G–I,
Phosphorylation of Cx36 at Ser293, a site known to regulate coupling through Cx36 gap
junctions (Ouyang et al., 2005), is also modulated by dopamine D1R signaling. Arrowheads
identify the locations of the same Cx36 gap junctions identified in D–F. D1R activation (H,
SKF38393, 10 µM) reduced Ser293-P labeling relative to control (G). D1R antagonism (I,
SCH23390, 100 µM) increased Ser293-P labeling. J, Quantification of the relationship
between AII amacrine cell coupling and Cx36 phosphorylation at Ser293. The mean ratio of
Ser293-P intensity to mCx36 intensity (across all Cx36 gap junctions in 3 images per injection)
is plotted against the diffusion coefficient for Neurobiotin tracer transfer calculated for each
injected AII amacrine cell network. The strong correlation of the data (r2 = 0.86) indicates a
direct relationship between AII amacrine cell coupling and Cx36 phosphorylation at Ser293.
Images are 2 µm-deep stacks. Scale bar in C is 50 µm; bar in F is 5 µm.
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Figure 2. PKA mediates D1R-dependent dephosphorylation of Cx36 at Ser293 in AII amacrine
cells
A & B, Under control conditions Ser293-P (green) labeling of Cx36 gap junctions (mCx36,
red) on AII amacrine cells (calretinin, blue) was heterogeneous. Annotated arrowheads indicate
pairs of Cx36 plaques along single dendrites that are in different phosphorylation states. The
close proximity of Cx36 plaques with widely varying Ser293-P labeling implies that regulation
is locally controlled at individual plaques. C & D, D1R activation (SKF38393, 100 µM) greatly
diminished Ser293-P labeling. E & F, Inhibition of PKA (Rp-8-CPT-cAMPS, 20 µM)
attenuated the dramatic reduction in Ser293-P labeling caused by SKF38393 (100 µM). G &
H, Antagonism of D1Rs (SCH23390, 100 µM) increased Ser293-P labeling. I, Summary of
data shows that inhibition of PKA significantly suppressed the reduction in Ser293
phosphorylation caused by D1R activation. J, Summary of data shows that changes in the
percentage of Cx36 plaques that show detectable Ser293-P labeling follows the same pattern
established for relative Ser293-P measurements in I. Error bars are s.e.m, n = 6. Asterisk
denotes P < 0.05, two asterisks denote P < 0.01. Images are 1 µm-deep stacks. Scale bar in
H is 10 µm.
Kothmann et al. Page 14
J Neurosci. Author manuscript; available in PMC 2010 May 25.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. Phosphorylation of Ser293 on Cx36 does not alter trafficking or distribution of the protein
A, Conditions that altered Cx36 phosphorylation at Ser293 (D1R activation, SKF38393, 100
µM; D1R antagonism, SCH23390, 100 µM) had no effect on the size of Cx36 plaques in AII
amacrine cells. Inhibition of PKA (Rp-8-CPT-cAMPS, 20 µM) also had no effect on Cx36
plaque size. B, Conditions that altered Cx36 phosphorylation at Ser293 (D1R activation,
SKF38393, 100 µM; D1R antagonism, SCH23390, 100 µM) had no effect on the overall
distribution of Cx36 plaques in AII amacrine cells. Inhibition of PKA (Rp-8-CPT-cAMPS, 20
µM) also had no effect on Cx36 plaque distribution. Error bars are s.e.m, n = 5. No significant
changes were found.
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Figure 4. PP2A is required for D1R-dependent dephosphorylation of Cx36 at Ser293 in AII
amacrine cells
A & B, Control; color scheme and antibodies are the same as Figure 2. C & D, D1R activation
(SKF38393, 10 µM) greatly diminished Ser293-P labeling. E & F, Inhibition of PP2A
(microcystin-LR, 0.5 nM) completely blocked the reduction in Ser293 phosphorylation caused
by D1R activation. G & H, Inhibition of PP2A alone led to increased phosphorylation of
Ser293. I, Summary of data shows that inhibition of PP2A significantly blocked the reduction
in Ser293 phosphorylation caused by D1R activation, and that PP2A inhibition alone
significantly increased Ser293 phosphorylation. J, Summary of data shows that changes in the
percentage of Cx36 plaques that show detectable Ser293-P labeling follows the same pattern
established for relative Ser293-P measurements in I. Error bars are s.e.m, n = 6. Asterisk
denotes P < 0.05, two asterisks denote P < 0.01. Images are 1 µm-deep stacks. Scale bar in
H is 10 µm.
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Figure 5. PP1 negatively regulates the dephosphorylation of Cx36
A & B, Control; color scheme and antibodies are the same as Figure 2. C & D, D1R activation
(SKF38393, 10 µM) greatly diminished Ser293-P labeling. E & F, Inhibition of PP1
(tautomycetin, 10 nM) did not alter the effects of D1R activation. G & H, Inhibition of PP1
alone was sufficient to cause a strong reduction in Ser293-P labeling. I, Summary of data shows
that inhibition of PP1 did not prevent the reduction in Ser293 phosphorylation caused by D1R
activation, and that PP1 inhibition alone significantly reduced Ser293 phosphorylation. J,
Summary of data shows that changes in the percentage of Cx36 plaques that show detectable
Ser293-P labeling follows the same pattern established for relative Ser293-P measurements in
I. Error bars are s.e.m, n = 4. Asterisk denotes P < 0.05, two asterisks denote P < 0.01. Images
are 1 µm-deep stacks. Scale bar in H is 10 µm.
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Figure 6. PP2A is required for PKA-dependent dephosphorylation of Cx36 at Ser293 in AII
amacrine cells
A & B, Control; color scheme and antibodies are the same as Figure 2. C & D, PKA activation
(Sp-8-CPT-cAMPS, 20 µM) greatly diminished Ser293-P labeling, just as D1R activation did.
E & F, Inhibition of PP2A (microcystin-LR, 0.5 nM) completely blocked the reduction in
Ser293 phosphorylation caused by PKA activation. G & H, Inhibition of PP2A alone slightly
increased Ser293 phosphorylation relative to control. I, Summary of data shows that inhibition
of PP2A significantly blocked the reduction in Ser293 phosphorylation caused by PKA
activation. We observed a trend towards increased Ser293 phosphorylation when PP2A alone
was inhibited, similar to the significant increase we observed previously with the same
treatment (Fig. 4). J, Summary of data shows that changes in the percentage of Cx36 plaques
that show detectable Ser293-P labeling follows the same pattern established for relative
Ser293-P measurements in I. Error bars are s.e.m, n = 5. Two asterisks denote P < 0.01. Images
are 1 µm-deep stacks. Scale bar in H is 10 µm.
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Figure 7. Model of D1R-dependent regulation of Cx36-mediated coupling between AII amacrine
cells
Activation of D1Rs (1) initiates a cascade leading to activation of PKA (2); both D1R and PKA
activation are sufficient to uncouple AII amacrine cells (Hampson et al., 1992; Mills and
Massey, 1995). In this study we showed that D1R-dependent dephosphorylation (grey P’s) of
Ser293 on Cx36 uncouples AII amacrine cells (3). We show that PP2A is required for both
D1R- and PKA-stimulated dephosphorylation of Ser293 (4). This provides evidence that the
D1R → PKA → PP2A pathway, which was recently described in spiny neurons in the striatum
and led to dephosphorylation of Thr75 on DARPP-32 (Ahn et al., 2007), is also present in the
AII amacrine cell. AII amacrine cells also express DARPP-32 (Partida et al., 2004; Witkovsky
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et al., 2007), and dephosphorylation of Thr75 on DARPP-32 facilitates PKA-mediated
phosphorylation (black P’s) of Thr34 (5), which converts DAPRR-32 into an inhibitor of PP1
(6) (Svenningsson et al., 2004). We found that PP1 negatively regulates the dephosphorylation
of Cx36, possibly by opposing PKA-mediated activation of PP2A (7). Our results indicate that
the D1R → PKA → PP2A pathway is not limited to striatal neurons, and may represent a
common pathway in neurons expressing D1Rs and DARPP-32.
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